Non-Hormonal Contraceptives Industry to See Robust Expansion, Valued at $33.48 Billion by 2029

"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.

What Is the Projected CAGR for the Non-Hormonal Contraceptives Market from 2024 to 2025?
In recent times, there has been a robust expansion in the size of the non-hormonal contraceptives market. The value of this market is projected to increase from $23.73 billion in 2024 to $25.47 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historic period, including increased backing for women's health initiatives, wider availability of non-hormonal contraceptive options that can be bought over-the-counter, more attention given to the development of male contraceptive products, escalating demand for contraceptive solutions based on fertility-awareness, and an increase in the number of approved products and introductions in the non-hormonal sector.

What are the Expected Market Size and CAGR for Non-Hormonal Contraceptives by 2029?
In the coming years, the non-hormonal contraceptives market is projected to experience significant growth, reaching $33.48 billion by 2029, with a compound annual growth rate (CAGR) of 7.1%. This anticipated advancement can be attributed to factors such as increased demand for hormone-free alternatives in birth control, heightened awareness of the adverse effects of hormonal contraceptives, growing preference for natural and chemical-free contraceptive options, an increase in cases of sexually transmitted diseases, and heightened health awareness among women especially regarding their reproductive health. Future trends within that period include the improvement of biomaterials used for non-hormonal contraceptive devices, technological innovation in the design of barrier contraceptives, smart tracking attributes incorporated with fertility-awareness methods, advance in the development of contraceptive gels and films that are drug-free, and technology-aided tools for self-application of contraceptive devices.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/non-hormonal-contraceptives-global-market-report

Which Factors Are Driving the Global Non-Hormonal Contraceptives Market Expansion?
The growing prevalence of sexually transmitted diseases is expected to propel the growth of the non-hormonal contraceptives market going forward. Sexually transmitted diseases (STDs) are infections mainly spread through sexual contact and caused by bacteria, viruses, or parasites. The increase in sexually transmitted diseases is largely attributed to a decline in con*dom usage, raising the likelihood of infection during unprotected sex. Non-hormonal contraceptives, including male and female con*doms, help prevent the transmission of sexually transmitted diseases by serving as a physical barrier that prevents the exchange of bodily fluids during sexual activity. For instance, in April 2025, according to the Minnesota Department of Health (MDH), a US-based state health agency, the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024. Therefore, the growing prevalence of sexually transmitted diseases is driving the growth of the non-hormonal contraceptives market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25849&type=smp

Which Segment Currently Holds the Largest Share of the Non-Hormonal Contraceptives Market?
The non-hormonal contraceptives market covered in this report is segmented -
1) By Type: Devices, Sterilization, Other Product Types
2) By Mechanism Of Action: Antagonist, Agonist, Inhibitor, Modulator
3) By Route of Administration: Intramuscular, Intravaginal, Intravenous, Oral, Subcutaneous, Topical, Transdermal, Other Route Of Administrations
4) By Purpose Of Therapy: Treatment Of Disease, Management Of Symptoms
5) By Target Indication: Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis, Other Target Indications

Subsegments:
1) By Devices: Surgical Instruments, Ligation Clips, Tubal Rings
2) By Sterilization: Permanent Sterilization, Reversible Sterilization, Mechanical Sterilization Devices
3) By Other Product Types: Non-Surgical Barrier Devices, Implantable Plugs, Intrauterine Permanent Devices

Which Major Trends Are Shaping the Future of the Non-Hormonal Contraceptives Industry?
Leading entities in the non-hormonal contraceptives market are striving to develop inventive solutions like preloaded intrauterine device delivery systems, aiming to streamline insertion procedures, add user-friendly attributes, and boost clinical efficacy. The term 'preloaded intrauterine device (IUD) delivery system' is used to describe a fully-assembled, ready-to-deploy device that merges the preloaded IUD and its inserter into a single unit, aiming to simplify the insertion process, cut down setup duration, and minimize the chances of contamination or procedural errors. For instance, in 2024, CooperSurgical Inc., a US-based firm specializing in medical devices and fertility, unveiled the Paragard Single-Handed Inserter, targeting improved efficiency of insertion and patient comfort during the placement of non-hormonal preloaded intrauterine devices. The device boasts of over 99% efficacy in long-term birth control up to a decade by inhibiting the fertilization of the egg by the sperm. Noteworthy advantages include immediate and reversible contraception, hormone-free adaptability, and minimal upkeep post-insertion.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25849&type=smp

Which Key Players Dominate the Non-Hormonal Contraceptives Industry Globally?
Major companies operating in the non-hormonal contraceptives market are Bayer AG., Chu*rch & Dwight Co., Mankind Pharma Limited, Okamoto Industries, CooperSurgical Inc., PSI India Pvt Ltd., Karex Berhad, Natural Cycles Nordic AB, Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Veru Inc., Evofem Biosciences Inc., Daré Bioscience Inc., Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, YourChoice Therapeutics Inc., Cirqle Biomedical Contraception ApS, Eppin Pharma Inc., Contraline Inc., Linepharma International Ltd.

What Are the Fastest-Growing Regions in the Non-Hormonal Contraceptives Market?
North America was the largest region in the non-hormonal contraceptives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out to Us
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.